Congress passes only veteran-focused psychedelic research funding (not broad access or rescheduling) in 2026.
Predicted 2026-07-14 · Resolves 2026-12-31 · legislation · USA
In 2026, the only psychedelic-related law Congress is likely to pass would fund research specifically for military veterans — not open up psychedelics to the general public or change their legal status. Veterans and PTSD (post-traumatic stress disorder) attract bipartisan political support in a way that broader drug policy reform simply doesn't. So lawmakers will fund studies, not freedom.
Resolution rule: YES if, as of 2026-12-31, any federal law enacted in 2026 (tracked via congress.gov) contains psychedelic-related provisions LIMITED to research/study funding (e.g., DoD/VA-directed psychedelic research), AND no enacted 2026 law reschedules or creates broad legal access to psilocybin/MDMA. NO if either no such research provision is enacted OR a broader access/rescheduling law is enacted. Checked 2026-12-31.
Research funding attracts bipartisan votes (esp. via NDAA/VA appropriations); rescheduling and broad access provisions lack the votes. The politically survivable path is narrow research language.